QUANTUM CORP /DE/
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
QMCO$16.30-4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts, unaudited)
| September 30, 2026 | March 31, 2026 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $67,416 | $15,572 |
| Restricted cash | 79 | 662 |
| Accounts receivable, net of allowance for credit losses of $3,733 and $3,234, respectively | 70,725 | 69,650 |
| Inventories, net | 21,907 | 16,103 |
| Prepaid expenses | 4,739 | 2,431 |
| Other current assets | 8,279 | 8,068 |
| Total current assets | 173,145 | 112,486 |
| Property and equipment, net | 8,675 | 9,284 |
| Goodwill | 12,969 | 12,969 |
| Right-of-use assets, net | 7,075 | 7,416 |
| Other long-term assets | 13,336 | 14,737 |
| Total assets | $215,200 | $156,892 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities: | ||
| Accounts payable | $36,419 | $29,342 |
| Accrued compensation | 11,100 | 12,428 |
| Deferred revenue, current portion | 75,156 | 75,654 |
| Term debt | — | 54,811 |
| Warrant liabilities | 83,255 | 14,105 |
| Other current liabilities | 18,651 | 19,457 |
| Total current liabilities | 224,581 | 205,797 |
| Deferred revenue, net of current portion | 42,300 | 39,030 |
| Convertible note | — | 90,034 |
| Operating lease liabilities | 7,799 | 8,172 |
| Other long-term liabilities | 12,734 | 12,716 |
| Total liabilities | 287,414 | 355,749 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ deficit | ||
| Preferred stock: | ||
| Preferred stock, 20,000 shares authorized; no shares issued as of September 30, 2026 and March 31, 2026, respectively | — | — |
| Common stock: | ||
| Common stock, $0.01 par value; 225,000 shares authorized; 39,541 and 14,638 shares issued and outstanding at September 30, 2026 and March 31, 2026, respectively | 395 | 146 |
| Additional paid-in capital | 1,172,297 | 853,974 |
| Accumulated deficit | (1,243,660) | (1,043,517) |
| Accumulated other comprehensive loss | (1,246) | (9,460) |
| Total stockholders' deficit | (72,214) | (198,857) |
| Total liabilities and stockholders' deficit | $215,200 | $156,892 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.